Knight Therapeutics Inc. ( OTCPK:KHTRF) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Amal Khouri - Chief Business Officer Arvind Utchanah - Chief Financial Officer Samira Sakhia - ...

If you want to protect your ocular health in the long and short term, avoid these behaviors. View Entire Post › ...

RICHMOND, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and second quarter 2025 financial ...

In line with the Trump administration’s goal to curb the United States’ reliance on overseas drug manufacturing, the FDA has ...

LipoVive is a particular weight loss supplement that recently caught my attention, not because of exaggerated promises ...

FDA approval of IBTROZI (taletrectinib) transformed Nuvation Bio into a commercial-stage company, driving $4.8 million in GAAP revenue, well above GAAP revenue estimates. Earnings per share (GAAP) was ...

The Hemp Feed Coalition (HFC) announced a significant milestone with the inclusion of hemp seed meal (HSM) for laying hens in ...

By going after an obscure regulatory designation he describes as a “loophole,” the health secretary has put an industry he ...

With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...

These decisions affect not just the archetypal Ivy League student many imagine—they affect people who grew up in places like ...

The FDA fast-tracks birelentinib, a dual inhibitor for relapsed CLL/SLL, promising new hope for patients facing treatment ...